Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells
- PMID: 23136600
- PMCID: PMC3490332
- DOI: 10.3892/etm_00000017
Human MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells
Abstract
Resistance to platinum-based chemotherapy frequently poses a serious problem in the treatment of head and neck squamous cell carcinoma. In this study, we isolated cisplatin-resistant cells from a head and neck squamous cell carcinoma cell line. The mismatch repair (MMR) system is known as one of the cisplatin-resistant mechanisms. When the expression levels of hMLH1 and hMSH2, a mismatch repair gene and its gene product, were analyzed, the hMLH1 mRNA and protein expression levels were significantly decreased in the cisplatin-resistant cell lines compared with a cisplatin-sensitive cell line. In addition, the microsatellite instability (MSI) phenotype was examined for the absence of MMR. Our data support the hypothesis that hMLH1 mRNA and protein expression levels are predictors of cisplatin sensitivity, but MSI was not involved in cisplatin resistance. The status of hMLH1 predicts the sensitivity of head and neck squamous cell carcinoma to platinum-based chemotherapy.
Figures




Similar articles
-
Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.Cancer. 2003 Nov 15;98(10):2199-206. doi: 10.1002/cncr.11770. Cancer. 2003. PMID: 14601090
-
Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.Oral Oncol. 2003 Feb;39(2):115-29. doi: 10.1016/s1368-8375(02)00028-3. Oral Oncol. 2003. PMID: 12509964
-
Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1.Eur J Cancer. 2000 May;36(7):925-31. doi: 10.1016/s0959-8049(00)00025-3. Eur J Cancer. 2000. PMID: 10785599
-
hMLH1 and hMSH2 expression in human hepatocellular carcinoma.Int J Oncol. 2001 Sep;19(3):567-70. Int J Oncol. 2001. PMID: 11494037
-
Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.Clin Cancer Res. 2000 Apr;6(4):1415-21. Clin Cancer Res. 2000. PMID: 10778972
Cited by
-
PMS2: a potential prognostic protein marker in oral squamous cell carcinoma.Med Oral Patol Oral Cir Bucal. 2021 Jul 1;26(4):e451-e458. doi: 10.4317/medoral.24303. Med Oral Patol Oral Cir Bucal. 2021. PMID: 33247565 Free PMC article.
-
The Mismatch Repair System (MMR) in Head and Neck Carcinogenesis and Its Role in Modulating the Response to Immunotherapy: A Critical Review.Cancers (Basel). 2020 Oct 16;12(10):3006. doi: 10.3390/cancers12103006. Cancers (Basel). 2020. PMID: 33081243 Free PMC article. Review.
-
Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma.Int J Clin Exp Pathol. 2022 Mar 15;15(3):131-144. eCollection 2022. Int J Clin Exp Pathol. 2022. PMID: 35414841 Free PMC article.
-
EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells.Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14144-14153. doi: 10.1073/pnas.1821752116. Epub 2019 Jun 24. Proc Natl Acad Sci U S A. 2019. PMID: 31235597 Free PMC article.
References
-
- Choong N, Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin. 2008;58:32–53. - PubMed
-
- Wozniak K, Blasiak J. Recognition and repair of DNA-cisplatin adducts. Acta Biochim Pol. 2002;49:583–596. - PubMed
-
- Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265–7279. - PubMed
-
- Yang Z, Faustino PJ, Andrews PA, Monastra R, Rasmussen AA, Ellison CD, Cullen KJ. Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemother Pharmacol. 2000;46:255–262. - PubMed
-
- Papouli E, Cejka P, Jiricny J. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Res. 2004;64:3391–3394. - PubMed
LinkOut - more resources
Full Text Sources